Ivenix
Acquired by Fresenius Kabi
Eliminating infusion-related patient harm.

Sector
Life SciencesCategory
MedtechLocation
Amesbury, MAInitial Investment
2011
Eliminating infusion-related patient harm.
Ivenix is dedicated to eliminating infusion-related patient harm, uniquely positioned at the crossroads of healthcare IT and infusion delivery. Ivenix was acquired by Fresenius Kabi in 2022.
